GIP and GLP‐1, the two incretin hormones: Similarities and differencesYutaka Seino, Daisuke Yabe|Journal of Diabetes Investigation|2010Cited by 707
Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I–<scp>III</scp> clinical trialsDaisuke Yabe, Yutaka Seino|Journal of Diabetes Investigation|2018Cited by 40